- Home
- ELVN vs XPRO Comparison
ELVN vs XPRO Comparison
Compare ELVN & XPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- XPRO
- Stock Information
- Founded
- ELVN 2016
- XPRO 1938
- Country
- ELVN United States
- XPRO United States
- Employees
- ELVN N/A
- XPRO N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- XPRO Oilfield Services/Equipment
- Sector
- ELVN Health Care
- XPRO Energy
- Exchange
- ELVN Nasdaq
- XPRO Nasdaq
- Market Cap
- ELVN 1.2B
- XPRO 1.1B
- IPO Year
- ELVN 2020
- XPRO 2013
- Fundamental
- Price
- ELVN $20.73
- XPRO $9.01
- Analyst Decision
- ELVN Strong Buy
- XPRO Buy
- Analyst Count
- ELVN 5
- XPRO 3
- Target Price
- ELVN $41.20
- XPRO $12.00
- AVG Volume (30 Days)
- ELVN 747.2K
- XPRO 1.2M
- Earning Date
- ELVN 08-12-2025
- XPRO 07-24-2025
- Dividend Yield
- ELVN N/A
- XPRO N/A
- EPS Growth
- ELVN N/A
- XPRO N/A
- EPS
- ELVN N/A
- XPRO 0.58
- Revenue
- ELVN N/A
- XPRO $1,720,185,000.00
- Revenue This Year
- ELVN N/A
- XPRO N/A
- Revenue Next Year
- ELVN N/A
- XPRO $4.25
- P/E Ratio
- ELVN N/A
- XPRO $15.49
- Revenue Growth
- ELVN N/A
- XPRO 10.48
- 52 Week Low
- ELVN $13.30
- XPRO $6.70
- 52 Week High
- ELVN $30.03
- XPRO $24.50
- Technical
- Relative Strength Index (RSI)
- ELVN 52.08
- XPRO 52.31
- Support Level
- ELVN $19.22
- XPRO $8.42
- Resistance Level
- ELVN $21.90
- XPRO $8.85
- Average True Range (ATR)
- ELVN 1.49
- XPRO 0.46
- MACD
- ELVN -0.19
- XPRO -0.02
- Stochastic Oscillator
- ELVN 39.43
- XPRO 48.50
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About XPRO Expro Group Holdings N.V.
Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA), and Asia-Pacific (APAC). The majority of its revenue is derived from North and Latin America (NLA) segment.